Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ibandronate sodium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
S0307 Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000437061, S0307, U10CA032102, SWOG-S0307, NCCTG-SWOG-S0307, ECOG-SWOG-S0307, NSABP-SWOG-S0307, CALGB-SWOG-S0307, CAN-NCIC-SWOG-S0307, NCT00127205
Study in Elderly Patients With Early Breast Cancer (ICE)
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 65 and over
Sponsor: Other
Protocol IDs: GBG 32, BIG 4-04, NCT00196859
A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 64
Sponsor: Other
Protocol IDs: GBG 33, GAIN, NCT00196872
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000478864, WCTU-ZICE, NCRI-ZICE, ROCHE-ZICE, ISRCTN13914201, EU-20613, EUDRACT-2005-001710-40, NCT00326820
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0960, NCI-2010-01024, NCT00824993
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML20684, NCT00502736
Start Over